The Silent Scar: Why Women Are Demanding Change to D&C Procedures
A common procedure following miscarriage, abortion, or childbirth – the dilation and curettage (D&C) – is facing increased scrutiny as women share harrowing stories of uterine scarring and infertility. Advocates and medical professionals are calling for tighter regulations and a shift towards safer practices, highlighting a potential turning point in women’s healthcare.
Asherman’s Syndrome: A Hidden Risk
Lily Johnstone, a Melbourne resident, dreamed of expanding her family. That dream is now uncertain after a D&C left her with Asherman’s syndrome, a condition characterized by scarring inside the uterus. “At the moment it kind of feels like that’s been taken away from me, so it’s very sad,” she shared. Ms. Johnstone’s experience isn’t isolated. Between 1 to 2 percent of women develop Asherman’s syndrome after undergoing a D&C.
The condition can lead to changes in menstruation, painful periods, and difficulty conceiving. It likewise carries risks of infection, complications during pregnancy, and even catastrophic bleeding after delivery.
Outdated Tools and a Lack of Accountability
At the heart of the concern is the continued leverage of sharp curettes – a looped metal tool with a cutting edge – despite recommendations from the World Health Organization (WHO) to utilize suction curettes, a blunt plastic tool, instead. The sharp curette, dating back to the 1840s, is considered by some, like obstetrician Thierry Vancaillie, a “museum piece” intended for diagnostic sampling, not treatment of miscarriage.
Advocates like Naomi Cate, co-founder of Asherman’s Australia, express frustration with the lack of regulatory change. “That reflects very low respect for women,” she stated. Ms. Cate herself was diagnosed with the condition after a postpartum D&C she was later told was unnecessary, and now advocates for safer treatment options.
A key issue is the absence of mandatory reporting of Asherman’s syndrome cases. Currently, the Therapeutic Goods Administration (TGA) classifies sharp curettes as a low-risk device, meaning adverse events don’t need to be reported, creating a data gap that hinders understanding the true scope of the problem.
The Push for Clinical Standards and Data Collection
The Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) issued guidelines last year recommending against the use of sharp curettes in D&Cs following miscarriage, but no such guidelines exist for postpartum procedures. RANZCOG president Dr. Nisha Khot expressed a desire to spot suction curettes used whenever possible.
Professor Vancaillie advocates for the routine use of ultrasound imaging during D&Cs to ensure complete tissue removal and minimize the risk of scarring. While beneficial, ultrasound isn’t universally available in surgical theaters, and not all clinicians are trained in its use.
The lack of comprehensive data is a significant obstacle. Dr. Khot emphasizes the need for an Asherman’s syndrome registry and increased research funding to better understand the condition and improve treatment outcomes.
What Does the Future Hold?
The growing awareness of Asherman’s syndrome and the potential risks associated with D&C procedures are likely to drive several key changes in women’s healthcare:
- Increased Regulation: Pressure will likely mount on regulatory bodies like the TGA to reclassify sharp curettes and mandate adverse event reporting.
- Wider Adoption of Suction Curettage: Hospitals and clinics will likely transition towards using suction curettage as the standard method for D&C procedures.
- Enhanced Ultrasound Utilization: Investment in ultrasound technology and training for clinicians will develop into more common to improve procedural accuracy and minimize complications.
- Improved Informed Consent: Clinicians will be expected to provide more detailed information to patients about the risks and benefits of D&C procedures, including the potential for Asherman’s syndrome.
- National Registries and Research: The establishment of national registries to track Asherman’s syndrome cases will be crucial for gathering data and informing future research efforts.
Frequently Asked Questions
What is Asherman’s syndrome? Asherman’s syndrome is a condition where scar tissue forms inside the uterus, often after a D&C procedure.
What are the symptoms of Asherman’s syndrome? Symptoms can include changes in menstrual cycles, painful periods, and difficulty getting pregnant.
Is a D&C always necessary? A D&C is often necessary to remove pregnancy tissue, but alternative methods should be considered when appropriate.
What can I do if I suspect I have Asherman’s syndrome? Consult with a gynecologist specializing in reproductive health for diagnosis and treatment options.
What is the difference between a sharp curette and a suction curette? A sharp curette has a cutting edge and can cause more scarring, while a suction curette uses gentle suction to remove tissue.
Did you know? The risk of developing Asherman’s syndrome after a D&C is relatively low (1-2%), but the consequences can be life-altering.
Pro Tip: Don’t hesitate to ask your doctor about all available options and potential risks before undergoing a D&C procedure.
Have you had a D&C and experienced complications? Share your story in the comments below to help raise awareness and support other women.
